|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.18 CHF | -2.93% |
|
-4.55% | -8.37% |
| Mar. 10 | Kuros Biosciences AG, 2025 Earnings Call, Mar 10, 2026 | |
| Mar. 10 | Kuros Biosciences AG Provides Earnings Guidance for the Year 2026-2028 | CI |
| Capitalization | 986M 1.25B 1.09B 944M 1.72B 116B 1.78B 11.78B 4.67B 55.2B 4.69B 4.59B 199B | P/E ratio 2025 |
588x | P/E ratio 2026 * | 64.6x |
|---|---|---|---|---|---|
| Enterprise value | 965M 1.22B 1.07B 923M 1.68B 113B 1.74B 11.52B 4.57B 53.98B 4.58B 4.49B 195B | EV / Sales 2025 |
9.46x | EV / Sales 2026 * | 5.31x |
| Free-Float |
67.49% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Kuros Biosciences AG
| 1 day | -2.93% | ||
| 1 week | -4.55% | ||
| Current month | -6.95% | ||
| 1 month | -0.24% | ||
| 3 months | -12.20% | ||
| 6 months | +7.15% | ||
| Current year | -8.37% |
| 1 week | 24.96 |  | 30.3 |
| 1 month | 24.64 | | 30.3 |
| Current year | 24.2 | | 30.3 |
| 1 year | 14 | | 34.2 |
| 3 years | 1.11 | | 34.2 |
| 5 years | 1.11 | | 34.2 |
| 10 years | 1.11 | | 38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christopher Fair
CEO | Chief Executive Officer | 56 | 2023-10-11 |
Joost de Bruijn
CEO | Chief Executive Officer | 60 | 2017-12-03 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 2023-02-16 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2018-06-13 | |
Joost de Bruijn
BRD | Director/Board Member | 60 | 2018-06-13 |
Oliver Walker
BRD | Director/Board Member | 57 | 2018-06-13 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.93% | -4.55% | +28.60% | +1,578.67% | 1.25B | |
| -0.36% | -1.35% | +11.40% | +85.44% | 42.98B | |
| -1.13% | -2.60% | +42.18% | +15.00% | 39.24B | |
| -0.01% | -0.45% | +82.23% | +661.46% | 30.07B | |
| +1.21% | -10.16% | -8.32% | -30.06% | 21.88B | |
| -1.71% | -5.01% | +29.53% | -30.75% | 18.25B | |
| -2.18% | -1.50% | +20.40% | -32.01% | 16.03B | |
| -0.81% | +2.70% | +53.06% | +171.76% | 12.97B | |
| +4.27% | +6.68% | -22.46% | +826.44% | 12.5B | |
| +1.75% | +2.23% | +58.17% | - | 11.76B | |
| Average | -0.19% | -1.17% | +29.48% | +360.66% | 20.69B | |
| Weighted average by Cap. | -0.19% | -1.35% | +31.07% | +189.32% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 134M 170M 149M 128M 234M 15.73B 243M 1.6B 636M 7.51B 638M 625M 27.14B | 177M 225M 196M 170M 309M 20.78B 321M 2.12B 840M 9.93B 843M 825M 35.85B |
| Net income | 9.2M 11.65M 10.18M 8.8M 16.01M 1.08B 16.64M 110M 43.55M 515M 43.72M 42.79M 1.86B | 18M 22.79M 19.92M 17.22M 31.32M 2.11B 32.56M 215M 85.22M 1.01B 85.53M 83.72M 3.64B |
| Net Debt | -21.77M -27.57M -24.1M -20.83M -37.88M -2.55B -39.38M -260M -103M -1.22B -103M -101M -4.4B | -45.04M -57.04M -49.86M -43.09M -78.37M -5.28B -81.47M -538M -213M -2.52B -214M -210M -9.1B |
Employees
158
Calendar
Aug. 13 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-13 | 25.18 CHF | -2.93% | 217,546 |
| 26-03-12 | 25.94 CHF | -8.79% | 485,607 |
| 26-03-11 | 28.44 CHF | -3.27% | 173,991 |
| 26-03-10 | 29.40 CHF | +10.61% | 815,545 |
| 26-03-09 | 26.58 CHF | +0.76% | 139,655 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
25.18CHF
Average target price
34.65CHF
Spread / Average Target
+37.61%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KURN Stock
Select your edition
All financial news and data tailored to specific country editions
